EU MDR and IVDR Harmonised Standards
EU MDR and IVDR Harmonised Standards
EU MDR and IVDR Harmonised Standards
COMMISSION
M/575
Brussels, 14.4.2021
C(2021) 2406 final
of 14.4.2021
EN EN
COMMISSION IMPLEMENTING DECISION
of 14.4.2021
1
OJ L 316, 14.11.2012, p. 12.
2
Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical
devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No
1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (OJ L 117, 5.5.2017, p. 1).
3
Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro
diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU
(OJ L 117, 5.5.2017, p. 176).
EN 1 EN
performance-based, they also contribute to ensuring equal conditions of competition
among economic operators dealing with devices, in particular small and medium-sized
enterprises that are active in this sector. Indirectly, those standards also contribute to
lower sales costs, benefitting patients and users in particular.
(4) Regulation (EU) 2017/745 replacing Council Directive 90/385/EEC 4 and Council
Directive 93/42/EEC5, and Regulation (EU) 2017/746 replacing Directive 98/79/EC of
the European Parliament and of the Council6 modify, among others, the requirements
regarding design and manufacture of devices, labelling and instructions for use of such
devices, and clinical investigation and performance studies concerning such devices.
Those Regulations also modify the rules on the quality management system and set
out detailed principles for the risk management requiring reduction of risks as far as
possible without adversely affecting the benefit-risk ratio.
(5) Several harmonised standards have been drafted in support of Directives 90/385/EEC,
93/42/EEC and 98/79/EC on the basis of standardisation mandates issued by the
Commission. Those harmonised standards need to be revised to take into account the
requirements set out in Regulations (EU) 2017/745 and (EU) 2017/746.
(6) Standards developed at international level by the International Organization for
Standardization (ISO) and the International Electrotechnical Commission (IEC) on the
basis of the Vienna agreement7 and the Frankfurt agreement8 need to be adopted as
harmonised standards by the European Committee for Standardization (CEN) and the
European Committee for Electrotechnical Standardization (Cenelec) after adapting
them to the Union legal framework.
(7) It is also necessary to draft new harmonised standards in relation to the requirements
set out in Regulations (EU) 2017/745 and (EU) 2017/746.
(8) The intention to request a review or an update of the existing harmonised standards
and drafting of new harmonised standards in support of Regulations (EU) 2017/745
and (EU) 2017/746 is stated in point 18 of the Commission Staff Working Document
on the implementation of the actions foreseen in the annual Union work programme
for European standardisation for 20189 accompanying that programme10.
(9) CEN and Cenelec have indicated that the work covered by the request falls within
their area of competence.
(10) It is therefore appropriate to request CEN and Cenelec to revise the existing
harmonised standards and to draft new harmonised standards in support of Regulations
(EU) 2017/745 and (EU) 2017/746.
(11) The harmonised standards should include detailed technical specifications in relation
to the requirements set out in Regulations (EU) 2017/745 and (EU) 2017/746,
especially with respect to the design and manufacture of devices, risk management and
the obligations on economic operators and sponsors, including those relating to quality
4
Council Directive 90/385/EEC of 20 June 1990 on the approximation of the laws of the Member States
relating to active implantable medical devices (OJ L 189, 20.7.1990, p. 17).
5
Council Directive 93/42/EEC of 14 June 1993 concerning medical devices (OJ L 169, 12.7.1993, p. 1).
6
Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro
diagnostic medical devices (OJ L 331, 7.12.1998, p. 1).
7
Agreement on technical co-operation between ISO and CEN (Version 3.3 of 20 September 2001).
8
IEC-CENELEC Agreement on common planning of new work and parallel voting (Edition 3 of
October 2016).
9
SWD(2017) 284 final of 25 August 2017.
10
COM(2017) 453 final of 25 August 2017.
EN 2 EN
management systems, risk management, clinical investigations and performance
studies, and clinical evaluation and clinical evidence. They should also indicate clearly
the correspondence between the technical specifications and the requirements they aim
to cover.
(12) In accordance with point 1 of Chapter I of Annex I to Regulation (EU) 2017/745 and
point 1 of Chapter I of Annex I to Regulation (EU) 2017/746, devices are to be safe
and effective and not compromise the clinical condition or the safety of patients, or the
safety and health of users or, where applicable, other persons, provided that any risks
which may be associated with their use constitute acceptable risks when weighed
against the benefits to the patient and are compatible with a high level of protection of
health and safety, taking into account the generally acknowledged state of the art.
Technical specifications included in the harmonised standards should support the
attainment of those objectives.
(13) In accordance with point (h) of section 23.1 of Chapter III of Annex I to Regulation
(EU) 2017/745 and point (h) of section 20.1 of Chapter III of Annex I to Regulation
(EU) 2017/746, the information supplied by the manufacturer of the device is to take
the form of internationally recognised symbols conforming to the harmonised
standards or common specifications. Moreover, in accordance with Article 10(11) of
Regulation (EU) 2017/745 and Article 10(10) of Regulation (EU) 2017/746, the use of
symbols in device information is to take into account the intended users or patients. In
order to ensure that users, patients and economic operators understand correctly the
meaning of any such symbols, a description of the meaning of the symbols should be
publicly available, without prejudice to any copyright to the relevant harmonised
standard or its parts.
(14) Information as to which legal requirements are covered or partially covered by a
harmonised standard is necessary when assessing, in accordance with Article 10(5) of
Regulation (EU) No 1025/2012, the compliance of the documents drafted by CEN and
Cenelec. Such information is also necessary before publication of references of
harmonised standards in the Official Journal of the European Union in accordance
with Article 10(6) of Regulation (EU) No 1025/2012. In each harmonised standard,
CEN and Cenelec should therefore specify the extent to which the technical
specifications included in the harmonised standard aim to cover one or several
requirements set out in Regulation (EU) 2017/745 or Regulation (EU) 2017/746.
(15) The European standardisation organisations have agreed to follow the Guidelines for
the execution of standardisation requests11.
(16) In order to ensure transparency and facilitate the execution of the requested
standardisation activities, CEN and Cenelec should prepare a work programme and
submit it to the Commission.
(17) In order to enable the Commission to better monitor the requested standardisation
work, CEN and Cenelec should provide the Commission with access to an overall
project plan containing detailed information on the execution of the standardisation
request and should report regularly on the execution of that request.
(18) Experience shows that during execution of the standardisation request, it may be
necessary to adjust the scope of the request or the deadlines set therein. CEN and
Cenelec should therefore promptly report to the Commission if they consider that
more time is required to draft the standards than initially foreseen or that it is
11
SWD(2015) 205 final of 27 October 2015.
EN 3 EN
appropriate to adapt the scope of the request in order to allow the Commission to take
appropriate action.
(19) In accordance with Article 10(3) of Regulation (EU) No 1025/2012, each
standardisation request is subject to acceptance by the relevant European
standardisation organisation. It is therefore necessary to provide for rules on the
validity of this request if it is not accepted by CEN or Cenelec.
(20) In order to ensure legal certainty as to the validity of the request after its execution, it
is appropriate to provide for a date of expiry of this Decision.
(21) Given that Directives 90/385/EEC and 93/42/EEC are repealed as of 26 May 2021 and
Directive 98/79/EC is repealed as of 26 May 2022, it is appropriate to provide for the
end of validity of standardisation mandates that have been issued by the Commission
for drafting harmonised standards in support of those Directives.
(22) Given that a standardisation request as regards medical devices in support of
Regulations (EU) 2017/745 and (EU) 2017/746 set out in Implementing Decision
C(2020) 253212 was not accepted by CEN and Cenelec, it is appropriate to repeal that
Decision.
(23) The European standardisation organisations, the European stakeholders’ organisations
receiving Union financing, and the Medical Device Coordination Group established by
Article 103 of Regulation (EU) 2017/745 have been consulted.
(24) Article 5(1) of Implementing Decision C(2020) 2532 contains an error by providing
for expiry of standardisation mandate ‘M/321 of 13 June 2002’ on 26 May 2020.
Mandate ‘M/321 of 13 June 2002’ is also referred to in Article 5(2) of Implementing
Decision C(2020) 2532 providing for its expiry on 26 May 2022, which is the correct
expiry date.
(25) The measures provided for in this Decision are in accordance with the opinion of the
Committee established by Article 22 of Regulation (EU) No 1025/2012,
HAS ADOPTED THIS DECISION:
Article 1
Requested standardisation activities
1. The European Committee for Standardization (CEN) and the European Committee
for Electrotechnical Standardization (Cenelec) are requested to revise the existing
harmonised standards listed in Table 1 of Annex I to this Decision and to draft the
new harmonised standards listed in Table 2 of that Annex in support of Regulation
(EU) 2017/745 for medical devices by the deadlines set in that Annex.
2. CEN and Cenelec are requested to revise the existing standards listed in Table 1 of
Annex II to this Decision and to draft the new harmonised standards listed in Table 2
of that Annex in support of Regulation (EU) 2017/746 for in vitro diagnostic medical
devices by the deadlines set in that Annex.
3. The standards referred to in paragraphs 1 and 2 shall meet the requirements set out in
Annex III.
12
Commission Implementing Decision C(2020) 2532 of 15 May 2020 on a standardisation request to the
European Committee for Standardization and the European Committee for Electrotechnical
Standardization as regards medical devices in support of Regulation (EU) 2017/745 of the European
Parliament and of the Council and in vitro diagnostic medical devices in support of Regulation (EU)
2017/746 of the European Parliament and of the Council.
EN 4 EN
4. CEN and Cenelec shall provide the Commission with the titles of the requested
standards in all official languages of the Union.
Article 2
Work programme
1. CEN and Cenelec shall prepare a joint work programme indicating all the standards
listed in Annexes I and II, the responsible technical bodies and a timetable for the
execution of the requested standardisation activities in line with the deadlines set out
in those Annexes.
2. CEN and Cenelec shall submit the joint work programme to the Commission by 28
May 2021. CEN and Cenelec shall inform the Commission of any amendments to the
joint work programme.
3. CEN and Cenelec shall provide the Commission with access to an overall project
plan.
Article 3
Reporting
1. CEN and Cenelec shall report annually to the Commission on the execution of the
standardisation request referred to in Article 1, indicating the progress made in
implementation of the work programme referred to in Article 2.
2. CEN and Cenelec shall submit the first joint annual report to the Commission by 16
April 2022. Subsequent joint annual reports shall be submitted to the Commission by
31 October each year.
3. CEN and Cenelec shall provide the Commission with the joint final report by 30
June 2024.
4. CEN and Cenelec shall promptly report to the Commission any major concerns
relating to the scope of the standardisation request referred to in Article 1 or the
deadlines set in Annexes I and II.
Article 4
Validity of the standardisation request
If CEN or Cenelec do not accept the standardisation request referred to in Article 1 within a
month of receiving it, the request may not constitute a basis for the standardisation activities
referred to in that Article.
This Decision shall expire on 31 December 2024.
Article 5
Expiry of existing standardisation mandates and repeal of Implementing Decision C(2020)
2532
1. The following standardisation mandates shall expire on 26 May 2022:
(a) M/252 of 12 September 1997;
(b) M/321 of 13 June 2002;
(c) M/384 of 6 April 2006.
2. Implementing Decision C(2020) 2532 is repealed.
EN 5 EN
Article 6
Addressees
This Decision is addressed to the European Committee for Standardization and the European
Committee for Electrotechnical Standardization.
Done at Brussels, 14.4.2021
EN 6 EN
EUROPEAN
COMMISSION
Brussels, 14.4.2021
C(2021) 2406 final
ANNEXES 1 to 3
ANNEXES
to the
EN EN
ANNEX I
List of existing standards to be revised and list of new standards to be drafted as
referred to in Article 1(1)
Table 1: List of existing harmonised standards to be revised and deadlines for the
adoption of the revised harmonised standards
EN 1 EN
9. EN 1865-1:2010+A1:2015 27 May 2024
EN 2 EN
Graphical symbols - Safety colours and safety signs -
Registered safety signs
EN 3 EN
Evaluation and testing within a risk management
process
EN 4 EN
Identification and quantification of degradation
products from polymeric medical devices
EN 5 EN
48. EN ISO 11140-1:2014 27 May 2024
EN 6 EN
penetration, flame spread and secondary ignition
EN 7 EN
Aseptic processing of health care products - Part 5:
Sterilization in place
EN 8 EN
subjects - Good clinical practice
EN 9 EN
87. EN ISO 14971:2019 27 May 2024
EN 10 EN
96. EN ISO 15883-7:2016 27 May 2024
EN 11 EN
Requirements for the development, validation and
routine control of a sterilization process for medical
devices
EN 12 EN
114. EN ISO 23908:2013 27 May 2024
EN 13 EN
performance
EN 14 EN
systems intended for use in the emergency medical
services environment
EN 15 EN
performance of nerve and muscle stimulators
EN 16 EN
monitoring equipment
EN 17 EN
requirements for the basic safety and essential
performance of invasive blood pressure monitoring
equipment
EN 18 EN
161. EN 60601-2-45:2011+A1:2015 27 May 2024
EN 19 EN
169. EN 60601-2-64:2015 27 May 2024
EN 20 EN
General requirements
EN 21 EN
186. EN ISO 80369-7:2017 27 May 2024
EN 22 EN
194. EN ISO 80601-2-56:2017+A1:2020 27 May 2024
EN 23 EN
Table 2: List of new harmonised standards to be drafted and deadlines for their
adoption
EN 24 EN
and auditory brainstem implant systems (ISO 14708-7)
17. Assistive products for personal hygiene that support 27 May 2024
users - Requirements and test methods (ISO 17966)
21. Lasers and laser-related equipment - Test methods for 27 May 2024
laser-induced damage threshold - Classification of
medical beam delivery systems (ISO 22248)
24. Medical electrical equipment - Part 4-5: Guidance and 27 May 2024
interpretation - Safety related technical security
specifications for medical devices (IEC TR 60601-4-5)
EN 25 EN
performance of electrocardiographs, including
diagnostic equipment, monitoring equipment,
ambulatory equipment, electrodes, cables and
leadwires (IEC 80601-2-86)
EN 26 EN
ANNEX II
List of existing standards to be revised and list of new standards to be drafted as
referred to in Article 1(2)
Table 1: List of existing harmonised standards to be revised and deadlines for the
adoption of the revised harmonised standards
EN 27 EN
systems and packaging systems
EN 28 EN
Aseptic processing of health care products - Part 7:
Alternative processes for medical devices and
combination products
EN 29 EN
measurement procedures
EN 30 EN
vitro diagnostic reagents for professional use
EN 31 EN
43. EN 61010-1:2010+A1:2019+AC:2019 27 May 2024
Safety requirements for electrical equipment for
measurement, control, and laboratory use - Part 1:
General requirements
45. EN 62304:2006+A1:2015
27 May 2024
Medical device software - Software life-cycle
processes
Table 2: List of new harmonised standards to be drafted and deadlines for their
adoption
EN 32 EN
ANNEX III
Requirements for the standards referred to in Article 1
Part A. General requirements
1. Legal requirements to be supported by the harmonised standards
The harmonised standards shall support application of relevant safety and
performance requirements for medical devices and in vitro diagnostic medical
devices for human use and system and process requirements for economic operators
and sponsors of clinical investigations and performance studies set out in Regulations
(EU) 2017/745 and (EU) 2017/746.
The harmonised standards shall provide detailed technical, scientific, processual or
methodological specifications of safety and performance requirements with the
purpose of allowing compliance with relevant requirements of Regulations (EU)
2017/745 and (EU) 2017/746. Where appropriate, the harmonised standards shall
include methods to verify compliance with such specifications.
The structure of a harmonised standard shall be such that a clear distinction can be
made between its clauses and sub-clauses, which are necessary for compliance with
the safety and performance requirements of Regulation (EU) 2017/745 or Regulation
(EU) 2017/746 that the standard aims to cover and those which are not. The
relationship between the clauses and sub-clauses of a harmonised standard and the
requirements of Regulation (EU) 2017/745 or Regulation (EU) 2017/746 shall be
indicated in the Annexes Z to each standard. The relevant requirements of
Regulations (EU) 2017/745 and (EU) 2017/746 shall be taken into account from the
beginning and throughout the process of developing of the standards.
The normative body of a harmonised standard shall not:
(a) make any references to Regulation (EU) 2017/745 or Regulation (EU)
2017/746 or reproduce their requirements;
(b) contradict any definitions set out in Regulations (EU) 2017/745 and (EU)
2017/746 or define any legally relevant terms not defined in those Regulations.
Where a definition in a harmonised standard differs from a definition of the same
term set out in Regulation (EU) 2017/745 or Regulation (EU) 2017/746, the
differences shall be indicated in the foreword of that standard and in its Annex Z.
That Annex shall also state that, for the purpose of using the standard in support of
the requirements set out in Regulations (EU) 2017/745 and (EU) 2017/746, the
definitions set out in those Regulations prevail.
Each harmonised standard developed on the basis of the standardisation request
referred to in Article 1 shall refer to this Decision.
Each revised harmonised standard shall contain information on significant changes
introduced in that standard.
2. Legal requirements to be covered by an individual harmonised standard
When one of the harmonised standards listed in Annex I or in Annex II does not
cover all relevant requirements applicable to devices or system or process
requirements falling under its scope, or when it covers such requirements only
partially, that standard shall include in its Annex Z information on the relevant
applicable requirements or parts thereof that are not covered by it.
EN 33 EN
Where appropriate, the harmonised standard shall include information as to whether
a particular requirement is addressed with regard to the design, manufacturing, or
packaging of the device.
3. Reduction of risk
The specifications of harmonised standards concerning the reduction of risk which
may be associated with the device shall take into account the general requirements
laid down in point 2 of Chapter I of Annex I to Regulation (EU) 2017/745 and in
point 2 of Chapter I of Annex I to Regulation (EU) 2017/746 to reduce risks as far as
possible without adversely affecting the benefit-risk ratio.
4. Normative references
Normative references included in a harmonised standard shall be clear and specific
and ensure identification of all specifications covered by the standard. Where a
standard refers to another standard or a clause in that standard, and that standard or
clause contains a further normative reference or references (‘a normative reference
chain’), the whole normative reference chain shall be clear and specific. Normative
reference chains shall be avoided.
Clauses of a standard, which do not provide for technical, scientific or
methodological specifications, but are limited to a normative reference to another
standard or a clause in that standard shall not claim coverage of the legal
requirements that are addressed in the standard normatively referred to.
Standards which do not ensure compliance with legal requirements on their own, but
require application of another standard, shall contain a clear statement to that effect.
They shall not claim coverage of the legal requirements covered by that other
standard.
Standards containing normative references to undated standards shall indicate the
dated version of any such referenced standard.
5. Publicly available description of the meaning of symbols
Where a harmonised standard provides a description of the meaning of symbols to be
used in the information supplied by the manufacturer that description shall be made
publicly available. Public availability of such descriptions shall not affect any
copyright to a harmonised standard or its parts.
Part B. Specific requirements
1. Requirements for all harmonised standards listed in Annexes I and II
The harmonised standards shall ensure safety and effectiveness of devices and a high
level of protection of health and safety of patients, users or others persons. They shall
reflect the generally acknowledged state of the art.
2. Requirements for certain specific standards listed in Annexes I and II
2.1 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization
residuals (EN ISO 10993-7:2008+AC:2009) and Part 17: Establishment of allowable
limits for leachable substances (EN ISO 10993-17:2009)
In the standard EN ISO 10993-7:2008+AC:2009, the method of calculation of residue
limits for ethylene oxide sterilant laid down in point 4.3.1 of that standard shall be
modified in such a way as to take into account also patients with a weight lower/higher
EN 34 EN
than 70 kg, in particular neonates and other patients with a weight substantially below
the adults’ standard weight of 70 kg.
In the standard EN ISO 10993-17:2009, the method of calculation of concomitant
exposure to ethylene oxide sterilant laid down in points 6.2.2 and 6.3.2 of that
standard shall be modified in such a way as to take into account certain clinical
situations involving use of several medical devices in neonates with a bodyweight
lower than 3,5 kg.
2.2 Medical devices - Symbols to be used with medical device labels, labelling and
information to be supplied - Part 1: General requirements (EN ISO 15223-1:2016)
The existing standard EN ISO 15223-1:2016 shall be modified by the addition of a
symbol which indicates that a device is a medical device or an in vitro diagnostic
medical device to facilitate application of section 23.2(q) of Chapter III of Annex I to
Regulation (EU) 2017/745 or section 20.2(e) of Chapter III of Annex I to Regulation
(EU) 2017/746, as appropriate.
2.3 Sharps injury protection - Requirements and test methods - Sharps protection features
for single-use hypodermic needles, introducers for catheters and needles used for
blood sampling (EN ISO 23908:2013)
The existing standard EN ISO 23908:2013 shall be modified by describing technical
solutions for safety-engineered mechanisms to be applied in design and manufacture
of devices to ensure compliance with points 11.1 and 22.2 of Chapter II of Annex I to
Regulation (EU) 2017/745. The standard shall apply to devices which are intended to
be used for administration and/or extraction of body/blood fluids and/or medicinal
substances.
2.4 Health software - Part 1: General requirements for product safety (EN 82304-1:2017)
The existing standard EN 82304-1:2017 shall be modified by ensuring a clear
separation between products (software) which fall within the scope of Regulation (EU)
2017/745 and those that do not, ensuring that there is no ambiguity on its legal effect
and on which products could claim presumption of conformity on its basis.
EN 35 EN